文献速递糖尿病

人类遗传学作为靶点验证模型:寻找糖尿病新疗法

Human genetics as a model for target validation: finding new therapies for diabetes.
PubMed 文献 · Diabetologia · 2017-04-26

2型糖尿病是全球性流行病,现有治疗不足以预防并发症,新疗法进展缓慢,传统临床前模型预测药效和安全性不足。人类遗传学提供互补模型评估因果机制以验证靶点,过去几十年的遗传学发现已准确预测2型糖尿病的治疗机制。单基因糖尿病研究为精准医学提供概念验证,本文讨论该范式在复杂疾病中的适用性及全基因组关联研究(GWAS)的局限性。

要点

  • 遗传扰动是「自然实验」,可独特反映调控特定靶点的长期效应
  • 过去几十年遗传学发现已准确预测2型糖尿病现有治疗机制
  • 将GWAS信号转化为疾病生物学是尚未解决的关键瓶颈

核心结论

  • 人类遗传学可作为互补模型用于前瞻性靶点验证,遗传学发现已准确预测2型糖尿病的治疗机制。
  • 单基因糖尿病研究为精准医学提供概念验证,该范式在复杂疾病中的适用性仍需讨论。
  • 将GWAS信号转化为疾病生物学是尚未解决的关键挑战。

研究设计与样本

  • 综述类文章,讨论人类遗传学作为靶点验证模型在糖尿病新疗法寻找中的应用。

主要发现

  • 过去几十年的遗传学发现已准确预测2型糖尿病目前已知的治疗机制。

临床怎么用

  • 作者认为人类遗传变异可用于前瞻性靶点验证,并为此建立了未来应用的框架。

局限性

  • 文章重点指出了与使用全基因组关联研究(GWAS)寻找糖尿病新疗法相关的一些局限性。
  • 将GWAS信号转化为疾病生物学是尚未解决的关键挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Type 2 diabetes is a global epidemic with major effects on healthcare expenditure and quality of life. Currently available treatments are inadequate for the prevention of comorbidities, yet progress towards new therapies remains slow. A major barrier is the insufficiency of traditional preclinical models for predicting drug efficacy and safety. Human genetics offers a complementary model to assess causal mechanisms for target validation. Genetic perturbations are 'experiments of nature' that provide a uniquely relevant window into the long-term effects of modulating specific targets. Here, we show that genetic discoveries over the past decades have accurately predicted (now known) therapeutic mechanisms for type 2 diabetes. These findings highlight the potential for use of human genetic variation for prospective target validation, and establish a framework for future applications. Studies into rare, monogenic forms of diabetes have also provided proof-of-principle for precision medicine, and the applicability of this paradigm to complex disease is discussed. Finally, we highlight some of the limitations that are relevant to the use of genome-wide association studies (GWAS) in the search for new therapies for diabetes. A key outstanding challenge is the translation of GWAS signals into disease biology and we outline possible solutions for tackling this experimental bottleneck.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Thomsen SK, Gloyn AL. Human genetics as a model for target validation: finding new therapies for diabetes. Diabetologia. 2017. PMID: 28447115. doi:10.1007/s00125-017-4270-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。